BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9849696)

  • 1. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian function after bone marrow transplantation during childhood.
    Thibaud E; Rodriguez-Macias K; Trivin C; Espérou H; Michon J; Brauner R
    Bone Marrow Transplant; 1998 Feb; 21(3):287-90. PubMed ID: 9489652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal function in long term survivors with B thalassemia major following bone marrow transplantation.
    De Sanctis V; Galimberti M; Lucarelli G; Angelucci E; Ughi M; Baronciani D; Polchi P; Giardini C; Vullo C; Bagni B
    Bone Marrow Transplant; 1993; 12 Suppl 1():104. PubMed ID: 8374545
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
    Diaz MA; Vicent MG; Madero L
    Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg).
    Grigg AP; McLachlan R; Zaja J; Szer J
    Bone Marrow Transplant; 2000 Nov; 26(10):1089-95. PubMed ID: 11108308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting gonadal function after bone marrow transplantation during childhood.
    Couto-Silva AC; Trivin C; Thibaud E; Esperou H; Michon J; Brauner R
    Bone Marrow Transplant; 2001 Jul; 28(1):67-75. PubMed ID: 11498747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function following chemotherapy for childhood Hodgkin's disease.
    Mackie EJ; Radford M; Shalet SM
    Med Pediatr Oncol; 1996 Aug; 27(2):74-8. PubMed ID: 8649323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of ovarian function after allografting of ovarian cortex between genetically non-identical sisters.
    Donnez J; Squifflet J; Pirard C; Jadoul P; Dolmans MM
    Hum Reprod; 2010 Oct; 25(10):2489-95. PubMed ID: 20663793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
    Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
    Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of gonadal function in post-pubertal patients after bone marrow transplantation during childhood objective].
    Pérez Rodríguez MJ; Alonso Blanco M; Otheo De Tejada Barasoain E; Maldonado Regalado MA; Muñoz Villa A; Barrio Castellanos R
    An Esp Pediatr; 2000 Oct; 53(4):324-9. PubMed ID: 11083981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan.
    Panasiuk A; Nussey S; Veys P; Amrolia P; Rao K; Krawczuk-Rybak M; Leiper A
    Br J Haematol; 2015 Sep; 170(5):719-26. PubMed ID: 25974284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late effects in children after bone marrow transplantation: a review.
    Locatelli F; Giorgiani G; Pession A; Bozzola M
    Haematologica; 1993; 78(5):319-28. PubMed ID: 8314162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
    Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years.
    Kulkarni S; Powles R; Treleaven J; Singhal S; Horton C; Sirohi B; Bhagawati N; Tait D; Saso R; Killick S; Pinkerton R; Atra A; Meller S; Mehta J
    Bone Marrow Transplant; 2000 Feb; 25(4):365-70. PubMed ID: 10723578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa).
    Bouligand J; Boland I; Valteau-Couanet D; Deroussent A; Kalifa C; Hartmann O; Vassal G
    Bone Marrow Transplant; 2003 Nov; 32(10):979-86. PubMed ID: 14595385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
    Somali M; Mpatakoias V; Avramides A; Sakellari I; Kaloyannidis P; Smias C; Anagnostopoulos A; Kourtis A; Rousso D; Panidis D; Vagenakis A
    Gynecol Endocrinol; 2005 Jul; 21(1):18-26. PubMed ID: 16048797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
    Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Puberty and ovarian function following cytostatic therapy in childhood].
    Distler W; Kuhrke H; Jürgens H; Graf M
    Geburtshilfe Frauenheilkd; 1986 Apr; 46(4):237-41. PubMed ID: 3086179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.